Vertex Pharmaceuticals
VRTX
#134
Rank
A$185.53 B
Marketcap
$720.44
Share price
-3.77%
Change (1 day)
35.91%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): A$0.47 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$10.33 Billion. In 2023 the company made an earning of A$6.84 Billion, an increase over its 2022 earnings that were of A$6.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.47 B-93.01%
2023 A$6.84 B3.19%
2022 A$6.63 B53.56%
2021 A$4.31 B-12.06%
2020 A$4.91 B118.45%
2019 A$2.24 B120.64%
2018 A$1.01 B1473.64%
2017 A$64.75 M197.6%
2016 A$21.76 M-102.97%
2015 -A$0.74 Billion-28.46%
2014 -A$1.03 Billion-51.5%
2013 -A$2.12 Billion-30584.68%
2012 A$6.92 M-95.47%
2011 A$0.15 B
2009 -A$0.92 Billion
2007 -A$0.64 Billion83.1%
2006 -A$0.35 Billion59.02%
2005 -A$0.22 Billion3.28%
2004 -A$0.22 Billion-38.16%
2003 -A$0.35 Billion
2000 -A$58.86 Million-20.38%
1999 -A$73.92 Million31.62%
1998 -A$56.16 Million91.05%
1997 -A$29.4 Million-36.24%
1996 -A$46.11 Million12.45%
1995 -A$41 Million27.4%
1994 -A$32.18 Million-1833.33%
1993 A$1.85 M-112.12%
1992 -A$15.32 Million175%
1991 -A$5.57 Million-12.2%
1990 -A$6.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$2.37 B 499.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.93 B 2,654.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.51 B 6,328.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.65 Billion-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$28.45 B 7,071.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.17 Billion-141.56%๐Ÿ‡บ๐Ÿ‡ธ USA